The second portion of the SELECT GLP-1 study is taking outlets by storm. Unfortunately, there's a lot that needs to be scrutinized regarding this study.
The Adverse Event rate exceeds 16%?!?! Expect massive class-action lawsuits to follow.
The Adverse Event rate exceeds 16%?!?! Expect massive class-action lawsuits to follow.